1 reply to this topic

[brucekeller]

https://www.business...us-sars-2021-12

 

The US Army is wrapping up early clinical trials on a vaccine it hopes will target all existing coronavirus variants. 

Named SpFN, for Spike Ferritin Nanoparticle, it has shown promise in non-human primate trials and early human trial results are expected "this month," according to a press release from the US Army Walter Reed Army Institute of Research released Thursday. 

The jab could also help protect against other coronaviruses beyond COVID-19, which could offer hope against future pandemics. 

 

 

Hopefully it doesn't take a decade to get through the phases. Would be nice to see Pfizer and Moderna etc get screwed out of their biannual money fountain, plus not have to worry about variants or a portion of new *demics and get rid of a good chunk of colds. 

[entre]

This is a vaccine likely to be either with the Mark of the Beast, or the one before the Mark of the Beast.  The best way for Evolution Adaptation Theory to lead to covid mutating outside the spike protein (the nightmare scenario), is for a vaccine to finally cover all mutation possibilities inside the spike protein.

Edited by entre, 23 December 2021 - 04:48 PM.